According to the American Association of Neurological Surgeons (AANS), Traumatic Brain Injury (TBI) is defined as a blow to the head or a penetrating head injury that disrupts the normal functioning of the brain. It can result when the head suddenly and violently hits an object or when an object pierces the skull and enters brain tissue.
In Traumatic Brain Injury patients, Neurologic Damage is divided into two types: Primary Damage and Secondary Damage. Primary damage includes Coup-Contrecoup Injury, Skull Fracture, Contusion/Bruise, and Nerve Damage. While secondary damage that occurs over time after the actual brain injury; may include infection, hypoxia (oxygen deprivation), edema (brain swelling), elevated intracranial pressure, infarction (death of brain tissue which results in loss of blood supply to that region of the brain), and hematoma (focal area of bleeding in the skull due to tearing of blood vessels).
Traumatic brain injury severity is commonly described as mild, moderate, or severe. Injury severity is based on the duration of loss of consciousness and/or coma rating scale or score, post-traumatic amnesia (PTA), and brain imaging results.
Get FREE sample copy at:
The Traumatic Brain Injury market report also covers emerging drugs, current treatment practices, Traumatic Brain Injury market share of the individual therapies, current and forecasted Traumatic Brain Injury Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Traumatic Brain Injury treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Traumatic Brain Injury Market Key Facts
Approximately, 2.8 million people sustain Traumatic Brain Injury annually in the United States, and every day 153 people in the United States die from injuries that include Traumatic Brain Injury as per Brain line organization.
As per the Centers for Disease Control and Prevention (CDC) report, in the last decade, rates of Traumatic Brain Injury-related deaths in men decreased from 27.8 to 25.4 per 100,000, and rates in women decreased from 9.6 to 9.0 per 100,000. Men had more than twice the rate of TBI-related deaths as compared to women.
Centers for Disease Control and Prevention reported that over the span of six years (2007–2013) Traumatic Brain Injury-related ED visits have increased by 47%, hospitalization rates decreased by 2.5% and death rates decreased by 5%.
Marek Majdan et al. estimated that about 57,000 Traumatic Brain Injury-related deaths and 1·5 million hospital discharges occurred in 2012 in Europe.
According to data from the Overall Analysis Center of Traffic Accidents, Traumatic Brain Injury accounts for 9.3% of 1,160,000 traffic accident injuries. However, of the 9,000 deaths in this data, 50.3% of those were due to Traumatic Brain Injury in Japan.
Key Benefits of Traumatic Brain Injury Market Report
Traumatic Brain Injury market report provides an in-depth analysis of Traumatic Brain Injury Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
The Traumatic Brain Injury market report will help in developing business strategies by understanding the Traumatic Brain Injury Market trends & developments, key players, and future market competition that will shape and drive the Traumatic Brain Injury market in the upcoming years.
The Traumatic Brain Injury market report covers Traumatic Brain Injury current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Traumatic Brain Injury market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Traumatic Brain Injury Market
Owing to the launch of upcoming therapies the Traumatic Brain Injury market size is expected to increase during the forecast period.
The Traumatic Brain Injury market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Traumatic Brain Injury market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Traumatic Brain Injury market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Traumatic Brain Injury Epidemiology
As per the American Association of Neurological Surgeons, “about 1.7 million cases of Traumatic Brain Injury occur in the U.S. every year. Approximately 5.3 million people live with a disability caused by TBI in the U.S. alone.”
The Traumatic Brain Injury epidemiology section covers insights about the historical and current Traumatic Brain Injury patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Traumatic Brain Injury Drugs Uptake and Key Market Players
The Traumatic Brain Injury Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Traumatic Brain Injury market or expected to get launched in the market during the study period. The analysis covers Traumatic Brain Injury market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the key Traumatic Brain Injury Companies involved in drug development include:
NeuroVive Pharmaceutical AB
And many others.
Traumatic Brain Injury therapies covered:
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Traumatic Brain Injury Competitive Intelligence Analysis
4. Traumatic Brain Injury Market Overview at a Glance
5. Traumatic Brain Injury Disease Background and Overview
6. Traumatic Brain Injury Patient Journey
7. Traumatic Brain Injury Epidemiology and Patient Population
8. Traumatic Brain Injury Treatment Algorithm, Current Treatment, and Medical Practices
9. Traumatic Brain Injury Unmet Needs
10. Key Endpoints of Traumatic Brain Injury Treatment
11. Traumatic Brain Injury Marketed Products
12. Traumatic Brain Injury Emerging Therapies
13. Traumatic Brain Injury Seven Major Market Analysis
14. Attribute Analysis
15. Traumatic Brain Injury Market Outlook (7 major markets)
16. Traumatic Brain Injury Access and Reimbursement Overview
17. KOL Views on the Traumatic Brain Injury Market.
18. Traumatic Brain Injury Market Drivers
19. Traumatic Brain Injury Market Barriers
21. DelveInsight Capabilities
Traumatic Brain Injury Epidemiology Forecast
DelveInsight’s Traumatic Brain Injury – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Traumatic Brain Injury in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Traumatic Brain Injury(TBI) Pipeline Insights
Traumatic Brain Injury(TBI) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Traumatic Brain Injury(TBI) market.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd. 2432
City: Las Vegas
Country: United States